US FDA Supplement Facility Inspection Numbers Back To Typical Along With GMP Problems Found

 
• By Malcolm Spicer

Supplement facility GMP inspections by FDA in 2022 along with the frequency of form 483s sent to firms following inspections return to roughly pre-pandemic annual numbers after dipping during 2020 and 2021.

• Source: Shutterstock

Firms marketing dietary supplements in the US are picking up right where they left off before the COVID-19 pandemic with the types of good manufacturing practices the Food and Drug Administration is finding.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation